BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007;47:74-79. [PMID: 17207233 DOI: 10.1111/j.1537-2995.2007.01066.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Hu XB, Yue QH, Zhang XQ, Xu XQ, Wen Y, Chen YZ, Cheng XD, Yang L, Mu SJ. Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China. Virol J 2009;6:199. [PMID: 19917138 DOI: 10.1186/1743-422X-6-199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013;13:e6590. [PMID: 23675384 DOI: 10.5812/hepatmon.6590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
3 Al Kanaani Z, Mahmud S, Kouyoumjian SP, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. R Soc Open Sci. 2018;5:180257. [PMID: 29765698 DOI: 10.1098/rsos.180257] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
4 Niazi SK, Bhatti FA, Salamat N, Ghani E, Tayyab M. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan. Transfusion 2015;55:1803-11. [PMID: 25648663 DOI: 10.1111/trf.13017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Yilmaz S, Unlu A, Cetinkaya RA, Yapar M, Avci IY, Yilmaz S, Eyigun CP. A strategical re-thinking on National Blood Donor Pool: Anti-HBc positivity related re-entry mechanisms. Transfus Apher Sci 2016;54:271-5. [PMID: 26928919 DOI: 10.1016/j.transci.2015.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Sood AK, Pangotra C, Manrai M. Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital. Med J Armed Forces India 2016;72:140-4. [PMID: 27257324 DOI: 10.1016/j.mjafi.2016.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
7 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Jahan M, Islam MA, Akbar SM, Takahashi K, Tabassum S, Rahman A, Haque MA, Biswas J, Mishiro S, Al-Mahtab M. Anti-HBc Screening of Blood Donors in Bangladesh: Relevance to Containment of HBV Propagation. J Clin Exp Hepatol 2016;6:115-8. [PMID: 27493459 DOI: 10.1016/j.jceh.2016.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Shastry S, Bhat SS. Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis 2011;3:e2011062. [PMID: 22220259 DOI: 10.4084/MJHID.2011.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
10 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
11 Allain JP, Cox L. Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 2011;18:461-6. [PMID: 21912252 DOI: 10.1097/MOH.0b013e32834bac10] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
12 Allain J, Opare-sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol 2016;13:643-53. [DOI: 10.1038/nrgastro.2016.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
13 Abd El Kader Mahmoud O, Abd El Rahim Ghazal A, El Sayed Metwally D, Elnour AM, Yousif GE. Detection of occult hepatitis B virus infection among blood donors in Sudan. J Egypt Public Health Assoc 2013;88:14-8. [PMID: 23528527 DOI: 10.1097/01.EPX.0000427065.73965.c8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
14 Beltrán M, Berrío-pérez M, Bermúdez MI, Rey-benito G, Camacho B, Forero P, Molina GC, Fals O, Pisciotti I, Oliveros Y, Cortés A, De La Hoz F. Detección de hepatitis B oculta en donantes de bancos sangre, Colombia 2008-2009. biomedica 2011;31:580. [DOI: 10.7705/biomedica.v31i4.446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98. [PMID: 26563120 DOI: 10.1007/s12072-015-9675-4] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 949] [Article Influence: 179.3] [Reference Citation Analysis]
16 Yuen M, Ka-ho Wong D, Lee C, Tanaka Y, Allain J, Fung J, Leung J, Lin C, Sugiyama M, Sugauchi F, Mizokami M, Lai C. Transmissibility of Hepatitis B Virus (HBV) Infection through Blood Transfusion from Blood Donors with Occult HBV Infection. Clinical Infectious Diseases 2011;52:624-32. [DOI: 10.1093/cid/ciq247] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
17 Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35664. [PMID: 27226804 DOI: 10.5812/hepatmon.35664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
18 Seto W, Yuen M. Hepatitis B Virus: Asian Perspective. In: Wong RJ, Gish RG, editors. Clinical Epidemiology of Chronic Liver Diseases. Cham: Springer International Publishing; 2019. pp. 99-116. [DOI: 10.1007/978-3-319-94355-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Fessehaye N, Naik D, Fessehaye T. Transfusion transmitted infections - a retrospective analysis from the National Blood Transfusion Service in Eritrea. Pan Afr Med J 2011;9:40. [PMID: 22145069 DOI: 10.4314/pamj.v9i1.71219] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
20 Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol. 2008;80:53-57. [PMID: 18041005 DOI: 10.1002/jmv.21046] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
21 Allain JP, Candotti D; ISBT HBV Safety Collaborative Group. Hepatitis B virus in transfusion medicine: still a problem? Biologicals 2012;40:180-6. [PMID: 22305086 DOI: 10.1016/j.biologicals.2011.09.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
22 Larrubia JR. Occult hepatitis B virus infection: a complex entity with relevant clinical implications. World J Gastroenterol. 2011;17:1529-1530. [PMID: 21472115 DOI: 10.3748/wjg.v17.i12] [Reference Citation Analysis]
23 Borhany M, Shamsi T, Boota S, Ali H, Tahir N, Naz A, Naseer I, Farzana T, Ansari S, Nadeem M. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost. 2011;17:651-655. [PMID: 21406412 DOI: 10.1177/1076029611398122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
24 El Ekiaby M, Lelie N, Allain J. Nucleic acid testing (NAT) in high prevalence–low resource settings. Biologicals 2010;38:59-64. [DOI: 10.1016/j.biologicals.2009.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
25 Gutiérrez-García ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1538-1542. [PMID: 21472117 DOI: 10.3748/wjg.v17.i12.1538] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
26 Dhawan HK, Marwaha N, Sharma RR, Chawla Y, Thakral B, Saluja K, Sharma SK, Thakur MK, Jain A. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008;14:5327-30. [PMID: 18785287 DOI: 10.3748/wjg.14.5327] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
27 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
28 Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus 2017;15:6-12. [PMID: 27416568 DOI: 10.2450/2016.0268-15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
29 Moiz B, Moatter T, Shaikh U, Adil S, Ali N, Mahar F, Shamsuddin N, Khurshid M. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Transfusion. 2014;54:1652-1659. [PMID: 24383918 DOI: 10.1111/trf.12521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
30 Alavian SM, Miri SM, Hollinger FB, Jazayeri SM. Occult Hepatitis B (OBH) in Clinical Settings. Hepat Mon 2012;12:e6126. [PMID: 23087749 DOI: 10.5812/hepatmon.6126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
31 Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001-1026. [PMID: 18454738 DOI: 10.1111/j.1537-2995.2008.01701.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
32 Kaur G, Kaur P. Syphilis testing in blood donors: an update. Blood Transfus 2015;13:197-204. [PMID: 25545876 DOI: 10.2450/2014.0146-14] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015;7:600-6. [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
34 Alshayea AI, Eid GE, El-Hazmi MM, Alhetheel AF. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J 2016;37:1114-9. [PMID: 27652363 DOI: 10.15537/smj.2016.10.14708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Waheed Y, Bin-rahat T, Safi SZ, Qadri I. Epidemiological patterns and risk factors associated with hepatitis B virus in Pakistani population. Asian Biomedicine 2010;4:547-54. [DOI: 10.2478/abm-2010-0069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012;19:9-22. [PMID: 22187943 DOI: 10.1111/j.1365-2893.2011.01511.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]